InvestorsHub Logo
Followers 0
Posts 1189
Boards Moderated 0
Alias Born 10/14/2009

Re: pendragon8062 post# 27196

Sunday, 09/19/2010 4:31:03 PM

Sunday, September 19, 2010 4:31:03 PM

Post# of 59551
pen - it's my personal belief that we are not in the same situation than NEPH. Deano has open lines of communication with the review team. I really do not have the patience to read through NEPH's issues. The rejection appears to have crossed over the transition period of the FDA personnel. I strongly believe that we will not have that issue of NSE.

JB